Broadcom, Verizon and CoreWeave Object to Stock Tokens on OKXICE
Nine companies have filed objections with the proposed trading venue, highlighting the gap between regulatory permission and corporate acceptance of tokenized shares.
Broadcom, Verizon and CoreWeave are among nine companies that have objected to tokenized versions of their shares being offered on OKXICE, according to the venue’s public notice. The objections put an early limit on the roster of stocks available to a venture seeking to move part of the US equity market onto blockchain infrastructure.
The Block reported the objections at 3:56 PM EDT on October 17. The underlying notice is dated October 15. The companies did not announce a coordinated decision on Saturday.
The notice also names Cerebras Systems, AppLovin, Applied Digital, Rocket Lab, Applied Optoelectronics and UnitedHealth Group. It identifies the objectors without explaining each company’s reasons. An objection to this venue does not, on its own, establish opposition to every possible form of tokenized stock trading.
A new trading channel meets issuer resistance
OKXICE’s disclosure describes a joint venture owned equally by Intercontinental Exchange Holdings and OKC USA Holding. Its proposed model uses permissioned liquidity pools, with tokenized shares paired against supported stablecoins. Participants must pass identity and sanctions checks before gaining access.
That structure brings questions familiar from conventional markets into a different trading environment: how prices are formed, how liquidity behaves and how shareholder rights reach the investor. A blockchain can record a transaction, but that record alone does not explain the legal claim the buyer receives or the quality of the execution.
Applied Optoelectronics cited uncertainty about price, liquidity and volatility, The Block reported, attributing the explanation to The Wall Street Journal. The Journal’s accessible report independently identifies Broadcom, Verizon and UnitedHealth among the companies pushing back.
The distinction between a company’s shares and an independently arranged token linked to those shares is especially relevant to investor understanding. A familiar company name on a trading screen does not establish that the company designed or endorsed the product.
What the SEC exemption permits
The Securities and Exchange Commission introduced its temporary innovation exemption on September 17. It provides conditional relief for certain tokenized securities venues and liquidity providers, allowing an alternative trading structure while the agency considers further rules.
The relief includes conditions covering shareholder rights, disclosure and access. A venue must verify that qualifying tokens preserve the rights of equivalent conventional shares. For stock tokenized by an unaffiliated third party, the issuer must receive written notice and an opportunity to object.
The SEC also requires trading in the tokenized stock to stop when the primary listing exchange halts the underlying stock. Limits on symbols and trading volume remain part of the framework. Regulatory permission therefore comes with boundaries; it does not amount to an unrestricted approval of every token product or venue.
Nasdaq’s position illustrates the distinction
Nasdaq’s published FAQ says it plans to opt out of having its own shares tokenized under the exemption. Its document also explains that qualifying tokenized stock must preserve equivalent ownership rights, including dividends, voting and liquidation rights. Products providing only synthetic exposure fall outside that definition.
These distinctions make the phrase “tokenized stock” insufficient as a complete product description. The investor still needs to know who maintains the underlying position, what rights are passed through and which market protections govern the venue. The explanation of how ETF creation and redemption link a traded product to its holdings examines a different structure for maintaining that connection.
For TTN, the significance of the objections is the practical constraint they place on distribution. A venue can build its technical infrastructure and qualify for regulatory relief while still facing a narrower product list than it originally envisaged. Winning issuer confidence is a separate commercial task.
The next evidence will be the venue’s final offering, explanations from issuers and the operation of the permitted products. The nine objections establish a specific boundary for OKXICE; they do not establish that tokenization across US markets has failed.